It was already described in SLE that the CD180-negative B cells are highly activated cells [16], and we previously reported that anti-CD180 antibody ligation resulted in decreased CD180 expression; thus, the diminished CD180 expression of NS memory B cells in NMOSD and MS might be a result of B cell activation via CD180. This evidence concerns the gene CD180 and myeloid sarcoma.